RSS Feed Print
Company Plans Another Study of Alzheimer's Drug
Posted: Wednesday, December 12, 2012 4:09 PM
Joined: 12/6/2011
Posts: 3326

(Source: USAToday) - Eli Lilly's experimental Alzheimer's drug has flashed potential to help with mild cases of the disease, but patients and doctors will have to wait a few more years to learn whether regulators will allow the drugmaker to sell it.

In August, Lilly said the intravenous treatment failed to slow memory decline in two late-stage studies of about 1,000 patients each. But scientists saw a statistically significant slowing when they combined trial data. Pooled results found 34% less mental decline in mild Alzheimer's patients compared with those on a fake treatment for 18 months. Researchers also saw a statistically significant result when they examined a subgroup of patients with mild cases of Alzheimer's disease.


Go to full story: